AEGON Asset Management (UK)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
AEGON Asset Management (UK)'s DGX Position: Q2 2026 in Review
AEGON Asset Management (UK) increased its Quest Diagnostics (DGX) stake by 19% in Q2 2026, buying an estimated $3.39M and bringing the position to 107,888 shares worth $22.9M. The position accounts for 0.24% of the portfolio, ranked #84.
AEGON Asset Management (UK) first reported a position in DGX in Q3 2016 and has held it in 18 quarters since. The position peaked at $42.4M in Q4 2022. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- AEGON Asset Management (UK) held 107,888 shares of Quest Diagnostics worth $22.9M as of Q2 2026.
- AEGON Asset Management (UK) bought 17,283 Quest Diagnostics shares in Q2 2026, an estimated $3.39M.
- Quest Diagnostics made up 0.24% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #84 holding.
- AEGON Asset Management (UK) first reported a position in Quest Diagnostics in Q3 2016 and has held it in 18 quarters since.
- AEGON Asset Management (UK)'s Quest Diagnostics position peaked at $42.4M in Q4 2022.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.